Dyskinesia in Parkinson's Disease: New Mechanisms and Molecular Targets
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".
Deadline for manuscript submissions: closed (10 March 2023) | Viewed by 23433
Special Issue Editors
Interests: Parkinson’s disease; dyskinesia; dopamine; serotonin; neurosteroids
Special Issue Information
Dear Colleagues,
L-DOPA still represents the most effective medication for alleviating motor symptoms of Parkinson’s disease. However, as the disease progresses and neuronal degeneration gets worse, the efficacy of L-DOPA is progressively reduced and motor complications, particularly L-DOPA-induced dyskinesia (LID), appear, complicating disease management.
A great contribution to the understanding of the mechanisms underlying LID has been achieved by the introduction of validated animal models of dyskinesia, mainly rodents and non-human primates. In this Special Issue, we will focus on peak-dose dyskinesia, the most troublesome type of dyskinesia, which can be reliably mimicked in such animal models.
This work aims at providing an updated overview on the mechanisms, circuits, and therapeutic approaches in dyskinesia by collecting a series of contributions from recognized international experts in this field working on either clinical or preclinical aspects.
Prof. Dr. Manolo Carta
Prof. Dr. Barbara Picconi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Parkinson’s disease
- L-DOPA-induced dyskinesia
- basal ganglia circuits
- motor impairments
- striatal synaptic alterations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.